N-Acetyl sulfapyridine
CAS : 19077-98-6
Ref. 3D-FA17047
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- N-[4-[(2-Pyridinylamino)sulfonyl]phenyl]acetamide4'-(2-Pyridylsulfamoyl)acetanilideN4-Acetylsulfapyridine
- 2-(N4-Acetylsulfanilamide)pyridine
- 2-(N4-Acetylsulfanilamido)pyridine
- Acetamide, N-(4-((2-pyridinylamino)sulfonyl)phenyl)-
- Acetanilide, 4'-(2-pyridylsulfamoyl)-
- Acetylsulfapyridine
- Brn 0269306
- Ccris 6818
- N(sup 4)-Acetylsulfapyridine
- N-(4-((2-Pyridinylamino)sulfonyl)phenyl)acetamide
- Voir d'autres synonymes
- N-[4-(pyridin-2-ylsulfamoyl)phenyl]acetamide
- N<sup>4</sup>-Acetylsulfapyridine
N-Acetyl sulfapyridine is a sulfa drug that is used to treat inflammatory bowel disease. It is also used in the treatment of nephrolithiasis and to reduce urea nitrogen levels in wastewater. N-Acetyl sulfapyridine has been shown to be effective for the treatment of bowel disease, but not for other types of inflammation. The mechanism of action for this drug is not fully understood, but it appears to be related to its ability to inhibit the activity of RNA polymerase. This may also account for its anti-inflammatory effects. The polymerase chain reaction method was used to determine the concentration of N-acetyl sulfapyridine in human serum samples and urine samples from patients with inflammatory bowel disease or nephrolithiasis. The kinetic data obtained were analyzed using an analytical method that included phase chromatography and a chromatographic method.